Morpholino

MO1-gipc1

ID
ZDB-MRPHLNO-060726-1
Name
MO1-gipc1
Previous Names
  • MO-ATG-1 (1)
Target
Sequence
5' - CGTCCCAATCCAAGTGGCATTTTTG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
translation-start blocker
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-gipc1
Phenotype
Phenotype resulting from MO1-gipc1
Phenotype of all Fish created by or utilizing MO1-gipc1
Phenotype Fish Conditions Figures
MAP kinase activity increased occurrence, abnormal WT + MO1-gipc1 standard conditions Fig. 1 from Ren et al., 2010
MAP kinase activity disrupted, abnormal WT + MO1-gipc1 standard conditions Fig. 1 from Ren et al., 2010
MAP kinase activity increased occurrence, abnormal WT + MO1-gipc1 chemical treatment: pharmaceutical Fig. 1 from Ren et al., 2010
posterior cardinal vein vascular sprouts decreased amount, abnormal WT + MO1-gipc1 + MO2-gipc1 standard conditions Fig. 4 from Hermans et al., 2010
thoracic duct decreased length, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 6 from Hermans et al., 2010
thoracic duct absent, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 6 from Hermans et al., 2010
intersegmental vessel absent, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 7 from Ren et al., 2010
posterior cardinal vein vascular sprouts absent, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 6 from Hermans et al., 2010
dorsal aorta angiogenic sprout immature, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 7 from Ren et al., 2010
posterior cardinal vein vascular sprouts decreased amount, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 6 from Hermans et al., 2010
dorsal longitudinal anastomotic vessel absent, abnormal y1Tg + MO1-gipc1 standard conditions Fig. 7 from Ren et al., 2010
thoracic duct absent, abnormal y1Tg + MO1-gipc1 + MO2-gipc1 standard conditions Fig. 3 from Hermans et al., 2010
vascular lymphangioblast decreased amount, abnormal y1Tg + MO1-gipc1 + MO2-gipc1 standard conditions Fig. 4 from Hermans et al., 2010
thoracic duct decreased length, abnormal y1Tg + MO1-gipc1 + MO1-nrp2a standard conditions Fig. 6 from Hermans et al., 2010
thoracic duct absent, abnormal y1Tg + MO1-gipc1 + MO1-nrp2a standard conditions Fig. 6 from Hermans et al., 2010
posterior cardinal vein vascular sprouts absent, abnormal y1Tg + MO1-gipc1 + MO3-flt4 standard conditions Fig. 6 from Hermans et al., 2010
thoracic duct decreased length, abnormal y1Tg + MO1-gipc1 + MO3-flt4 standard conditions Fig. 6 from Hermans et al., 2010
posterior cardinal vein vascular sprouts decreased amount, abnormal y1Tg + MO1-gipc1 + MO3-flt4 standard conditions Fig. 6 from Hermans et al., 2010
thoracic duct absent, abnormal y1Tg + MO1-gipc1 + MO3-flt4 standard conditions Fig. 6 from Hermans et al., 2010
Citations